We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

CRISPR and Genome Editing – Products

Application Note

Gene Modification for Cell Therapy Applications

The clinical success of CAR T-cell therapy has spurred increased interest and investments in the advanced therapeutics industry.
Whitepaper

Affinity Chromatography Solutions for Commercial Adeno-Associated Virus Manufacturing

Download this whitepaper to learn more about improving AAV yield and purity using affinity resins as well as how affinity purification can contribute to viral clearance.
Application Note

CRISPR Engineered Cells Enable Variant Disease Modeling

Comprehensive disease modeling can be challenging for many labs due to variations in reagents, cell culture conditions, technical inconsistencies across protocols and experiments and bandwidth limitations.
Product News

INTEGRA Biosciences and MACHEREY-NAGEL Partner To Automate NucleoSpin® Nucleic Acid Purification Kits

INTEGRA Biosciences has collaborated closely with MACHEREY-NAGEL to develop automated protocols for a variety of NucleoSpin® RNA and DNA extraction and purification kits on the ASSIST PLUS pipetting robot.
Product News

DeNovix Launches Nuclei Counting Apps for CellDrop Automated Cell Counters

DeNovix Inc has developed two dedicated nuclei counting apps capable of differentiating isolated nuclei and intact cells from debris.
Product News

Optimized Lentiviral Vectors To Speed Up Your Research

AMSBIO offers a range of lentivirus production services to provide tailor-made products to support your research.
Product News

ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement

ERS Genomics Limited is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD.
Product News

TetraScience Launches Revolutionary Scientific Data Cloud

TetraScience has announced the evolution of its data cloud to include manufacturing and quality control data.
Product News

MaxCyte Signs Strategic Platform License With LG Chem To Advance its Allogeneic CAR-T Programs

MaxCyte, Inc. has announced the signing of a strategic platform license with LG Chem Ltd.
Application Note

Analysis of Lipid Nanoparticle Composition

In recent years, interest in lipid nanoparticle (LNP) research has increased due to promising opportunities for RNA-based therapy and gene-editing technology, and LNPs are showing promise as nucleic acid delivery vehicles in the pharmaceutical industry.
Advertisement